
### [NCIT:C6960](http://purl.obolibrary.org/obo/NCIT_C6960)
**Label:** Oligodendroglial Tumor

**Subclasses:** [NCIT:C4535](http://purl.obolibrary.org/obo/NCIT_C4535) (Spinal Cord Oligodendroglioma), [NCIT:C4326](http://purl.obolibrary.org/obo/NCIT_C4326) (Anaplastic Oligodendroglioma), [NCIT:C3288](http://purl.obolibrary.org/obo/NCIT_C3288) (Oligodendroglioma), [NCIT:C115359](http://purl.obolibrary.org/obo/NCIT_C115359) (Recurrent Childhood Anaplastic Oligodendroglioma), [NCIT:C4014](http://purl.obolibrary.org/obo/NCIT_C4014) (Adult Oligodendroglioma), [NCIT:C114773](http://purl.obolibrary.org/obo/NCIT_C114773) (Childhood Brain Oligodendroglioma), [NCIT:C5447](http://purl.obolibrary.org/obo/NCIT_C5447) (Childhood Anaplastic Oligodendroglioma), [NCIT:C4045](http://purl.obolibrary.org/obo/NCIT_C4045) (Childhood Oligodendroglioma), [NCIT:C9376](http://purl.obolibrary.org/obo/NCIT_C9376) (Adult Brain Oligodendroglioma), [NCIT:C9377](http://purl.obolibrary.org/obo/NCIT_C9377) (Brain Oligodendroglioma), [NCIT:C115371](http://purl.obolibrary.org/obo/NCIT_C115371) (Recurrent Childhood Oligodendroglioma), [NCIT:C8270](http://purl.obolibrary.org/obo/NCIT_C8270) (Adult Anaplastic Oligodendroglioma), [NCIT:C129319](http://purl.obolibrary.org/obo/NCIT_C129319) (Oligodendroglioma, Not Otherwise Specified), [NCIT:C129318](http://purl.obolibrary.org/obo/NCIT_C129318) (Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted), [NCIT:C129322](http://purl.obolibrary.org/obo/NCIT_C129322) (Anaplastic Oligodendroglioma, Not Otherwise Specified), [NCIT:C129321](http://purl.obolibrary.org/obo/NCIT_C129321) (Anaplastic Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted), [NCIT:C68691](http://purl.obolibrary.org/obo/NCIT_C68691) (Adult Oligodendroglial Tumor), 

**Class expressions from DL-Learner:**

- Thing 54.81%
- [NCIT:C79099](http://purl.obolibrary.org/obo/NCIT_C79099) (1p/19q Codeletion) 51.43%
- [NCIT:C6833](http://purl.obolibrary.org/obo/NCIT_C6833) (Double Minutes) 51.43%
- [NCIT:C41428](http://purl.obolibrary.org/obo/NCIT_C41428) (Increased Cellularity Present) 51.43%
- [NCIT:C38328](http://purl.obolibrary.org/obo/NCIT_C38328) (Unfavorable Clinical Outcome) 51.43%
- [NCIT:C36636](http://purl.obolibrary.org/obo/NCIT_C36636) (Loss of Chromosome 9p) 51.43%
- [NCIT:C36524](http://purl.obolibrary.org/obo/NCIT_C36524) (Loss of Chromosome 7) 51.43%
- [NCIT:C36512](http://purl.obolibrary.org/obo/NCIT_C36512) (Loss of Chromosome 10p) 51.43%
- [NCIT:C36506](http://purl.obolibrary.org/obo/NCIT_C36506) (Loss of Chromosome 22q) 51.43%
- [NCIT:C36505](http://purl.obolibrary.org/obo/NCIT_C36505) (Loss of Chromosome 11p) 51.43%
- [NCIT:C36504](http://purl.obolibrary.org/obo/NCIT_C36504) (Loss of Chromosome 6) 51.43%
- [NCIT:C36490](http://purl.obolibrary.org/obo/NCIT_C36490) (Loss of Chromosome 14) 51.43%
- [NCIT:C36454](http://purl.obolibrary.org/obo/NCIT_C36454) (Gain of Chromosome 7) 51.43%
- [NCIT:C35960](http://purl.obolibrary.org/obo/NCIT_C35960) (High Mitotic Activity) 36.78%
- [NCIT:C35960](http://purl.obolibrary.org/obo/NCIT_C35960) (High Mitotic Activity) and (not ([NCIT:C3994](http://purl.obolibrary.org/obo/NCIT_C3994) (Stage IV Colon Cancer AJCC v6))) 36.78%


